Standard Biotools (LAB) Amortization of Deferred Charges (2017 - 2026)
Standard Biotools (LAB) posted quarterly Amortization of Deferred Charges of $1.4 million for Q1 2026, down 5.77% year-over-year from $1.4 million in Q1 2025, and down 13.69% quarter-over-quarter from $1.6 million in Q3 2025.
Standard Biotools (LAB) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Amortization of Deferred Charges for 10 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 5.77% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $5.8 million (changed 0.07% YoY), while the FY2023 annual figure was $770000.0, down 7.23% from the prior year.
- Amortization of Deferred Charges eased to $1.4 million in Q1 2026 per LAB's latest filing, from $1.6 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.6 million in Q3 2025 and bottomed at $173000.0 in Q4 2023.
- Historically, Amortization of Deferred Charges has averaged $782533.3 across 5 years, with a median of $212000.0 in 2022.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges sank 51.99% — and 2024, when it jumped 648.13%.
- Standard Biotools' Amortization of Deferred Charges stood at $202000.0 in 2022, then slipped by 14.36% to $173000.0 in 2023, then jumped by 708.67% to $1.4 million in 2024, then advanced by 12.22% to $1.6 million in 2025, then retreated by 13.69% to $1.4 million in 2026.
- Business Quant data shows LAB's Amortization of Deferred Charges at $1.4 million in Q1 2026, $1.6 million in Q3 2025, and $1.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 173,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Sep 30, 2023 | 187,000.00 |